PuSH - HMGU Publikationen https://push-zb.helmholtz-munich.de PuSH - Publikationen-Server des Helmholtz Zentrums München de-de <![CDATA[Maxwell, M.* et al. INTASYL self-delivering RNAi decreases TIGIT expression, enhancing NK cell cytotoxicity: A potential application to increase the efficacy of NK adoptive cell therapy against cancer. Cancer Immunol. Immunother. 73:239 (2024)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=71891&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=71891&la=de Thu, 31 Oct 2024 00:00:00 +0000 <![CDATA[Stock, S.* et al. Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma. Cancer Immunol. Immunother. 73:100 (2024)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=70539&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=70539&la=de Wed, 05 Jun 2024 00:00:00 +0000 <![CDATA[Bao, X.* et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC. Cancer Immunol. Immunother. 70, 189-202 (2021)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59698&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59698&la=de Wed, 30 Sep 2020 00:00:00 +0000 <![CDATA[Scheuerpflug, A.C. et al. The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors. Cancer Immunol. Immunother. 70, 1343–1350 (2021)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60480&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60480&la=de Thu, 12 Nov 2020 00:00:00 +0000 <![CDATA[Thaiss, W.M.* et al. Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients. Cancer Immunol. Immunother. 70, 1263-1275 (2021)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60452&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60452&la=de Tue, 08 Dec 2020 00:00:00 +0000 <![CDATA[Metzger, P.* et al. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Cancer Immunol. Immunother. 69, 2101–2112 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59201&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59201&la=de Wed, 27 May 2020 00:00:00 +0000 <![CDATA[Orth, M.F.* et al. A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas. Cancer Immunol. Immunother. 69, 1353-1362 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=58813&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=58813&la=de Wed, 15 Apr 2020 00:00:00 +0000 <![CDATA[Gouttefangeas, C.* ; Schuhmacher, J.* & Dimitrov, S. Adhering to adhesion: Assessing integrin conformation to monitor T cells. Cancer Immunol. Immunother. 68, 1855-1863 (2019)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=56577&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=56577&la=de Thu, 01 Aug 2019 00:00:00 +0000 <![CDATA[Cirac, A. et al. Epstein-Barr virus strain heterogeneity impairs human T-cell immunity. Cancer Immunol. Immunother. 67, 663-674 (2018)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52825&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52825&la=de Tue, 30 Jan 2018 00:00:00 +0000 <![CDATA[Dislich, B.* et al. Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: Comparison between primary tumors and metastases. Cancer Immunol. Immunother. 66, 777-786 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=50709&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=50709&la=de Thu, 16 Mar 2017 00:00:00 +0000 <![CDATA[Lichtenegger, F.S. et al. RNA and protein expression of Herpesvirus Entry Mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. Cancer Immunol. Immunother. 64, 1505-1515 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=46823&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=46823&la=de Thu, 24 Sep 2015 00:00:00 +0000 <![CDATA[Schilling, D. ; Kühnel, A.* ; Tetzlaff, F.* ; Konrad, S.* & Multhoff, G. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells. Cancer Immunol. Immunother. 64, 599-608 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=43455&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=43455&la=de Thu, 26 Feb 2015 00:00:00 +0000 <![CDATA[Naujoks, M. et al. Alterations of costimulatory molecules and instructive cytokines expressed by dendritic cells in the microenvironment of an endogenous mouse lymphoma. Cancer Immunol. Immunother. 63, 491-499 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=30819&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=30819&la=de Sun, 23 Mar 2014 00:00:00 +0000 <![CDATA[Subklewe, M. et al. New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia. Cancer Immunol. Immunother. 63, 1093-1103 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=32116&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=32116&la=de Tue, 09 Sep 2014 00:00:00 +0000 <![CDATA[Battke, C. et al. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII. Cancer Immunol. Immunother. 60, 649-658 (2011)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3752&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3752&la=de Wed, 22 Jun 2011 00:00:00 +0000 <![CDATA[Battke, C. et al. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol. Immunother. 60, 639-648 (2011)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5390&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5390&la=de Wed, 22 Jun 2011 00:00:00 +0000 <![CDATA[Bukur, J.* ; Nößner, E. & Seliger, B.* 'Tumor immunology meets oncology (TIMO) VII' from 15th to 16th of April 2011 in Halle/Saale, Germany. Cancer Immunol. Immunother. 60, 1647-1653 (2011)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=6624&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=6624&la=de Mon, 07 Nov 2011 00:00:00 +0000 <![CDATA[Roider, E.* et al. Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer. Cancer Immunol. Immunother. 60, 371-380 (2011)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=6101&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=6101&la=de Fri, 31 Dec 2010 00:00:00 +0000 <![CDATA[Djafarzadeh, R.* et al. TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis. Cancer Immunol. Immunother. 58, 361-371 (2009)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2400&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2400&la=de Thu, 31 Dec 2009 00:00:00 +0000 <![CDATA[Bernhard, H. et al. Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer. Cancer Immunol. Immunother. 57, 271-280 (2008)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2522&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2522&la=de Mon, 10 Mar 2008 00:00:00 +0000 <![CDATA[Lang, S.* et al. Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition. Cancer Immunol. Immunother. 56, 1645-1652 (2007)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=27650&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=27650&la=de Mon, 31 Dec 2007 00:00:00 +0000 <![CDATA[Hacker, U.T.* et al. Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity. Cancer Immunol. Immunother. 55, 547-557 (2006)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4981&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4981&la=de Thu, 21 Sep 2006 00:00:00 +0000 <![CDATA[Milani, V.* & Nößner, E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol. Immunother. 55, 312-319 (2006)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4607&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4607&la=de Thu, 19 Oct 2006 00:00:00 +0000 <![CDATA[Nößner, E. Thermal stress-related modulation of tumor cell physiology and immune responses. Cancer Immunol. Immunother. 55, 289-291 (2006)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2848&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2848&la=de Tue, 14 Nov 2006 00:00:00 +0000 <![CDATA[Kufner, S.* et al. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunol. Immunother. 54, 953-970 (2005)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5537&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5537&la=de Tue, 03 Jan 2006 00:00:00 +0000 <![CDATA[Meyer, R.G.* ; Drexler, I. ; Sutter, G. & Jakob, T. A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr). Cancer Immunol. Immunother. 54, 453-467 (2005)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3992&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3992&la=de Wed, 10 Aug 2005 00:00:00 +0000 <![CDATA[Simons, P.J.* ; Oostendorp, R.A.J. ; Tas, M.P.R.* & Drexhage, H.A.* Comparison of retroviral p15E-related factors and interferon α in head and neck cancer. Cancer Immunol. Immunother. 38, 178-184 (1994)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=39999&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=39999&la=de Sat, 31 Dec 1994 00:00:00 +0000